Franklin, Parlapiano, Turner & Welch, LLC Novartis Ag Transaction History
Franklin, Parlapiano, Turner & Welch, LLC
- $387 Million
- Q3 2024
A detailed history of Franklin, Parlapiano, Turner & Welch, LLC transactions in Novartis Ag stock. As of the latest transaction made, Franklin, Parlapiano, Turner & Welch, LLC holds 75,244 shares of NVS stock, worth $7.79 Million. This represents 2.24% of its overall portfolio holdings.
Number of Shares
75,244
Previous 75,477
0.31%
Holding current value
$7.79 Million
Previous $8.04 Million
7.7%
% of portfolio
2.24%
Previous 2.23%
Shares
29 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$838 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$723 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$597 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $223B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...